source
- EMA leaders say single pivotal trial should not be default, decision must match evidence neededEMA chief Emer Cooke and other officials weighed in on the ongoing debate about the number of pivotal trials required for drug approval. They argued that requiring a single pivotal trial as a rigi…
- Trump administration claims all states will join Medicaid drug pricing program, but several states remain undecidedWhite House officials announced that every U.S. state had agreed to participate in a new federal Medicaid drug pricing initiative, describing it as a "good deal" for states. State officials, howev…